Table 2.
Outcome indices of the Action Plan (medical sector).
| Resistance Rate to Antimicrobials in Bacterial Isolates | ||
|---|---|---|
| Indices | 2013 | 2020 (Target) |
| Insensitivity rate to penicillins in Streptococcus pneumoniae isolates | 47.4% | ≤15% |
| Resistance rate to fluoroquinolones in Escherichia coli isolates | 35.5% | ≤25% |
| Resistance rates to methicillins in Staphylococcus aureus isolates | 51.1% | ≤20% |
| Resistance rates to carbapenems in Pseudomonas aeruginosa isolates | 17.1% | ≤10% |
| Resistance rates to carbapenems in E. coli and Klebsiella pneumoniae isolates | 0.1–0.3% | ≤0.2% (similar level) |
| Use of Antimicrobials (Defined Daily Doses per 1000 Inhabitants per Day) | ||
| Indices | 2013 | 2020 (Target) |
| Total | 14.91 | ≤2/3 (vs. 2013 level) |
| Oral cephalosporins, fluoroquinolones, and macrolides | 3.91, 2.83, and 4.83, respectively | Reduction by 50% (vs. 2013 level) |
| Intravenous antimicrobials | 0.96 | Reduction by 20% (vs. 2013 level) |